Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Strata Critical Medical, Inc.NASDAQ: SRTA

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation outflow grows to $0

Q1 FY2026 stock-based compensation was $0, compared with $0 a year earlier. Trailing-twelve-month stock-based compensation was $6.59M. Over 3 fiscal years it compounded at +29.2% a year.

Context

  • Stock-based compensation amounted to 9.0% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly stock-based compensation holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.65M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$17.83M-10.4% YoY
LTMMar 2026
$6.59M+21.9% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-10.4%——
3-year CAGR+29.2%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
17.83M USD
Year-over-year change
-10.4%
4-year CAGR
+16.7%

Stock-Based Compensation vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +21.9% is the 4th highest of 9, against a peer median of -8.2%.
  • Stock-based compensation amounts to 2.6% of revenue for SRTA, versus a peer median of 0.9%.
SRTA Competitors
Stock-Based Compensation for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZIPZipRecruiter, Inc.LTM Mar 2026$41.39M USD-31.5%-14.8%9.3%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$40.05M USD—+91.2%45.5%
KFRCKforce Inc.LTM Mar 2026$13.68M USD-3.7%-8.0%1.0%
EVTLVertical Aerospace Ltd.LTM Mar 2026£10.35M GBP—-25.3%—
MTRXMatrix Service CompanyLTM Mar 2026$7.63M USD-12.7%+4.2%0.9%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$6.59M USD+21.9%+29.2%2.6%
ORNOrion Group Holdings, Inc.LTM Mar 2026$5.9M USD+23.5%+25.5%0.7%
CYRXCryoport, Inc.LTM Mar 2026$4.96M USD-71.4%-18.1%2.7%
FLYXflyExclusive, Inc.LTM Mar 2026$2.59M USD+143.2%—0.7%
EBFEnnis, Inc.LTM Feb 2026$1.93M USD-51.5%—0.5%
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$1.03M USD+121.1%+27.2%0.1%
Peer median (excluding SRTA) —-8.2%-1.9%0.9%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.